Smar NetworkSmar.inSmargrid.comNewsInsuranceRoomsGamesMeasurementsCooking

Insurance Daily News

Daily news and analysis on insurance industry trends, regulations, and market insights

Facebook Telegram
← Back to Insurance News

Florida OIR fines PBMs over $12 million after market conduct exams

📅 2026-11-17 | 📰 Insurance Journal
#florida pbm fines #pharmacy benefit managers #oir market conduct #prescription drug reform act #network adequacy

Florida’s Office of Insurance Regulation (OIR) has imposed fines exceeding $12 million on 12 pharmacy benefit managers (PBMs) after market conduct examinations mandated by Senate Bill 1550, the Prescription Drug Reform Act signed in 2023. The examinations focused on PBMs’ pricing models, unilateral contract changes and compliance with state statutes on network adequacy.

The largest penalties were levied against Employee Health Insurance Management ($2.4 million), Scrip World – a CVS Health Corp. subsidiary ($2.2 million), Right Rx FL ($2.1 million) and Capital Rx Inc. ($1.6 million). Most PBMs have accepted the findings and begun corrective actions, but Capital Rx, now operating as Judi Rx under Judi Health, contested all eight red-flag items cited in the August 28 report. Examiners noted that 19 % of the contracts reviewed for Capital Rx omitted required network-adequacy language, a breach of Florida law. The PBM argued its contracts already contain language guaranteeing member access to a pharmacy network that meets reasonable standards.

Florida Insurance Commissioner Michael Yaworsky emphasized the need for transparency and accountability, warning that PBMs cannot hide revenue, retain rebates or raise costs for patients reliant on critical prescriptions. He reiterated that Florida’s laws will be enforced and PBMs will be held responsible for non-compliance.

The fines reflect growing national scrutiny of PBMs, with pharmacists and consumer groups alleging opaque practices that pressure pharmacies and increase drug prices. The OIR’s biennial examination authority under the 2023 reform law provides a mechanism for state oversight and enforcement.

Why it matters

The penalties signal heightened regulatory focus on PBM practices, affecting insurers’ pharmacy benefit strategies and cost structures.

FAQ

What law gave OIR authority to examine PBMs?
Florida Senate Bill 1550, the Prescription Drug Reform Act signed in 2023.

Which PBM disputed all findings in the OIR report?
Capital Rx, now Judi Rx under Judi Health, contested all eight red-flag items.

What was the fine amount for Employee Health Insurance Management?
$2.4 million.

What percentage of Capital Rx contracts lacked required network-adequacy terms?
19 % of the contracts reviewed.

Source: Insurance Journal. See the original source for full details.